Inactive Instrument
BiVictriX Therapeutics plc Stock
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 01/01/2016 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 03/10/2023 |
Alison Halsall
SEC | Corporate Secretary | - | 13/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 01/01/2016 |
Susan Lowther
BRD | Director/Board Member | 67 | 22/09/2021 |
William Paris
BRD | Director/Board Member | 75 | 22/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/09/24 | Buy | Director | 20,000 | 0.0242% | ||
| 02/09/24 | Sell | Director | 20,000 | 0.0242% | ||
| 13/08/24 | Free | Executive/Senior Manager | 320,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| -0.25% | -1.70% | +1.76% | +19.86% | 48.84B | |
| +4.07% | +2.43% | +483.70% | +623.80% | 45.44B | |
| +4.33% | +0.98% | +12.80% | +88.53% | 41.22B | |
| +1.94% | -0.31% | +26.24% | +12.62% | 39.71B | |
| -0.50% | 0.00% | +20.60% | +60.49% | 32.6B | |
| +0.10% | -3.22% | - | - | 16.25B | |
| +3.22% | -0.88% | +30.42% | +135.47% | 16.67B | |
| -0.69% | -0.52% | +3.27% | +28.92% | 14.08B | |
| +2.35% | +3.48% | +82.95% | +43.41% | 13.68B | |
| Average | +3.22% | +0.02% | +82.72% | +126.64% | 29.83B | |
| Weighted average by Cap. | +1.82% | +0.03% | +103.06% | +153.41% |
Employees
-
